Literature DB >> 12055127

Enzymatic activation of endothelial protease-activated receptors is dependent on artery diameter in human and porcine isolated coronary arteries.

Justin R Hamilton1, James D Moffatt, James Tatoulis, Thomas M Cocks.   

Abstract

Protease-activated receptor (PAR)-mediated vascular relaxations have been compared in coronary arteries of different diameters isolated from both humans and pigs. Thrombin, trypsin, and the PAR1-activating peptide, TFLLR, all caused concentration-dependent relaxation of both large (epicardial; approximately 2 mm internal diameter) and small (intramyocardial; approximately 200 microm internal diameter) human coronary arteries. EC(50) values for thrombin (0.006 u ml(-1) in epicardial, 1.69 u ml(-1) in intramyocardial) and trypsin (0.02 u ml(-1) in epicardial, 1.05 u ml(-1) in intramyocardial) were significantly (P<0.01) greater in intramyocardial arteries. By contrast, EC(50) values for TFLLR were not different between epicardial (0.35 microM) and intramyocardial (0.43 microM) arteries. In porcine coronary arteries, EC(50) values for relaxations to thrombin (0.03 u ml(-1) in epicardial 0.17 u ml(-1) in intramyocardial) were also significantly (P<0.01) greater in the smaller arteries. EC(50) values for both TFLLR and the PAR2-activating peptide, SLIGKV, were not different between the two different-sized pig coronary arteries. PAR1-immunoreactivity was localized to the endothelium of human epicardial and intramyocardial arteries and both PAR1- and PAR2-immunoreactivity was observed in endothelial cells of equivalent porcine arteries. These findings indicate that enzymatic activation of endothelial cell PARs in human (PAR1) and porcine (PAR1 and PAR2) coronary arteries is markedly reduced in intramyocardial arteries when compared with epicardial arteries, suggesting increased regulation of PAR-mediated vascular responses in resistance-type arteries.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12055127      PMCID: PMC1573372          DOI: 10.1038/sj.bjp.0704714

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  63 in total

1.  Human bradykinin B(2) receptor is activated by kallikrein and other serine proteases.

Authors:  C Hecquet; F Tan; B M Marcic; E G Erdös
Journal:  Mol Pharmacol       Date:  2000-10       Impact factor: 4.436

Review 2.  Small-artery changes in hypertension.

Authors:  A M Heagerty; A S Izzard
Journal:  J Hypertens       Date:  1995-12       Impact factor: 4.844

3.  Role of matrix metalloproteinase-2 in thrombin-induced vasorelaxation of rat mesenteric arteries.

Authors:  C Fernandez-Patron; M W Radomski; S T Davidge
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-05       Impact factor: 4.733

4.  An assay for high-sensitivity detection of thrombin activity and determination of proteases activating or inactivating protease-activated receptors.

Authors:  L M Altrogge; D Monard
Journal:  Anal Biochem       Date:  2000-01-01       Impact factor: 3.365

5.  Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.

Authors:  E Camerer; W Huang; S R Coughlin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

6.  Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart.

Authors:  C Napoli; C Cicala; J L Wallace; F de Nigris; V Santagada; G Caliendo; F Franconi; L J Ignarro; G Cirino
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

7.  Properties of P2X and P2Y receptors are dependent on artery diameter in the rat mesenteric bed.

Authors:  D P Gitterman; R J Evans
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

8.  Heterogeneous mechanisms of endothelium-dependent relaxation for thrombin and peptide activators of protease-activated receptor-1 in porcine isolated coronary artery.

Authors:  J R Hamilton; T M Cocks
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 9.  Thrombin signalling and protease-activated receptors.

Authors:  S R Coughlin
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

10.  Nitric oxide, prostanoid and non-NO, non-prostanoid involvement in acetylcholine relaxation of isolated human small arteries.

Authors:  N H Buus; U Simonsen; H K Pilegaard; M J Mulvany
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

View more
  4 in total

Review 1.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

2.  Modulation of PAR(1) signalling by benzimidazole compounds.

Authors:  S Asteriti; S Daniele; F Porchia; M T Dell'Anno; A Fazzini; I Pugliesi; M L Trincavelli; S Taliani; C Martini; M R Mazzoni; A Gilchrist
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

3.  Quercetin and its major metabolites selectively modulate cyclic GMP-dependent relaxations and associated tolerance in pig isolated coronary artery.

Authors:  S Suri; X H Liu; S Rayment; D A Hughes; P A Kroon; P W Needs; M A Taylor; S Tribolo; V G Wilson
Journal:  Br J Pharmacol       Date:  2009-12-24       Impact factor: 8.739

4.  The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia.

Authors:  Candice E Junge; Taku Sugawara; Guido Mannaioni; Sudar Alagarsamy; P Jeffrey Conn; Daniel J Brat; Pak H Chan; Stephen F Traynelis
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-14       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.